ADALIMUMAB
DrugBank ID: db00051
DrugCentral: adalimumab
Synonymous :adalimumab (genetical recombination) | adalimumab-adaz | adalimumab-adbm | adalimumab-afzb | adalimumab-atto | adalimumab-bwwd
Drug Sentece Context
Table 1. Analysis of context sentence of adalimumab gene in 3 abstracts.
pmid | sentence |
---|---|
32441764 | PARPi’s may potentiate the effectiveness of Tocilizumab, Anakinra, Sarilumab, Adalimumab, Canakinumab or Siltuximab therapy. |
32696108 | Specific immune modulators include anti-cytokines such as interleukin (IL)-1 and IL-6 receptor antagonists (e.g. anakinra, tocilizumab, sarilumab, siltuximab), Janus kinase (JAK) inhibitors (e.g. baricitinib, ruxolitinib), anti-tumor necrosis factor-α (e.g. adalimumab, infliximab), granulocyte-macrophage colony-stimulating factors (e.g. gimsilumab, lenzilumab, namilumab), and convalescent plasma, with promising to negative trials and other data. |
32789106 | The man had been under treatment for 2 years with Adalimumab, a tumor-necrosis-factor (TNF) inhibitor, for ulcerative colitis. |